Cue Biopharma
76 hedge funds and large institutions have $35M invested in Cue Biopharma in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-24
Holders Change %
-24%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
29
Reduced
26
Closed
32
Calls
$160K
Puts
$173K
Net Calls
-$13K
Net Calls Change
-$373K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.5M |
| 2 |
MAM
2
Monaco Asset Management
Monaco
|
$1.11M |
| 3 |
3
Morgan Stanley
New York
|
$1.09M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$508K |
| 5 |
CC
5
Carlson Capital
Dallas,
Texas
|
$1.44M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Russell Investments Group
London,
United Kingdom
| – | -$5K | -1,203 | Closed |
|
102
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$6K | -1,197 | Closed |
|
103
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -293 | Closed |
|